NEW YORK (Reuters Health) – In a retrospective study of patients with severe sepsis or septic shock, those who received a single-dose of etomidate before rapid sequence intubation…
NEW YORK (Reuters Health) – In a prospective study, the beta-1 selective blocker bisoprolol proved more effective than the non-selective beta-blocker carvedilol in preventing atrial fibrillation after coronary…
Join us for continued coverage of the 33rd CTRC-AACR San Antonio Breast Cancer Symposium, Day 3. Participants in the San Antonio Breast Cancer Symposium today heard evidence that…
Join us for continued coverage of the 33rd CTRC-AACR San Antonio Breast Cancer Symposium, Day 4. In one of our final reports from the San Antonio Breast Cancer…
Join us for complete coverage of the 33rd CTRC-AACR San Antonio Breast Cancer Symposium, Day 2. Several papers describing research into the screening and management of breast cancer…
Join us for complete coverage of the 33rd CTRC-AACR San Antonio Breast Cancer Symposium, Day 2. Several papers describing research into the screening and management of breast cancer…
Join us for continued coverage of the 33rd CTRC-AACR San Antonio Breast Cancer Symposium, Day 1. The long-awaited AZURE Trial – The Carry-Over Effect of Adjuvant Zoledronic Acid:…
NEW YORK (Reuters Health) – Smoking does not affect outcomes after early clopidogrel use in patients with acute coronary syndrome (ACS), according to findings published in the November…
NEW YORK (Reuters Health) – Patients with generalized anxiety disorder (GAD) are best treated with an antidepressant for at least 12 months, according to a study published in…
NEW YORK (Reuters Health) – There’s no need for people to stop taking aspirin before an immunochemical fecal occult blood test (iFOBT) because it won’t hamper the performance…
Join us for complete coverage of the 33rd CTRC-AACR San Antonio Breast Cancer Symposium, Day 1. Several papers describing research into the screening and management of breast cancer…
NEW YORK (Reuters Health) – Brachytherapy is a viable option for prostate cancer patients 60 and younger, the authors of a new report in BJUI conclude. “Prostate cancer…
